发明申请
- 专利标题: 9-Substituted 8-oxoadenine compound
- 专利标题(中): 9-取代的8-氧代腺嘌呤化合物
-
申请号: US10593691申请日: 2005-03-24
-
公开(公告)号: US20070190071A1公开(公告)日: 2007-08-16
- 发明人: Ayumu Kurimoto , Kazuki Hashimoto , Yoshiaki Isobe , Stephen Brough , Ian Millichip , Hiroki Wada , Roger Bonnert , Thomas Mcinally
- 申请人: Ayumu Kurimoto , Kazuki Hashimoto , Yoshiaki Isobe , Stephen Brough , Ian Millichip , Hiroki Wada , Roger Bonnert , Thomas Mcinally
- 申请人地址: JP Osaka 541-8524 SE Soedertaelje SE-151 85
- 专利权人: Dainippon Sumitomo Pharma Co., Ltd.,AstraZeneca Aktiebolag
- 当前专利权人: Dainippon Sumitomo Pharma Co., Ltd.,AstraZeneca Aktiebolag
- 当前专利权人地址: JP Osaka 541-8524 SE Soedertaelje SE-151 85
- 优先权: JP2004-093672 20040326
- 国际申请: PCT/JP05/05401 WO 20050324
- 主分类号: A61K31/52
- IPC分类号: A61K31/52 ; A61K31/522 ; C07D473/10
摘要:
The present invention provides an 8-oxoadenine compound having immunemodulating activities such as an interferon inducing activity and useful as an antiviral agent and antiallergic agent, which is represented by the following formula (1): [wherein the ring A represents a 6-10 membered aromatic carbocyclic ring and the like, R represents a halogen atom, an alkyl group and the like, n represents an integer of 0-2, Z1 represents alkylene, X2 represents oxygen atom, sulfur atom, SO2, NR5, CO, CONR5, NR5CO and the like, Y1, Y2 and Y3 represent independently a single bond or an alkylene group, X1 represents oxygen atom, sulfur atom, NR4 (R4 is hydrogen atom or an alkyl group) or a single bond, R2 represents a substituted or unsubstituted alkyl group, R1 represents hydrogen atom, hydroxy group, an alkoxy group, an alkoxycarbonyl group or a haloalkyl group]or its pharmaceutically acceptable salt.
公开/授权文献
- US08012964B2 9-substituted 8-oxoadenine compound 公开/授权日:2011-09-06
信息查询
IPC分类: